Lomedeucitinib |
| カタログ番号GC71456 |
Lomedeucitinib (bms-986322)は受容体チロシンプロテインキナーゼ(tyk2)を標的としている。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2328068-29-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Lomedeucitinib (BMS-986322) is act by targeting receptor tyrosine protein kinase (TYK2). Lomedeucitinib can be used for the research of plaque psoriasis.
References:
[1]. Lomedeucitinib by Bristol-Myers Squibb for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval.
Review for Lomedeucitinib
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Lomedeucitinib
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *